Cargando…
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Cancer immunotherapy especially immune checkpoint inhibition has achieved unprecedented successes in cancer treatment. However, there are many patients who failed to benefit from these therapies, highlighting the need for new combinations to increase the clinical efficacy of immune checkpoint inhibi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677403/ https://www.ncbi.nlm.nih.gov/pubmed/33214545 http://dx.doi.org/10.1038/s41392-020-00347-9 |